Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Mitocholine Ltd | 16 |
| 2 | BASF Schweiz AG | 5 |
| 3 | Ratiopharm GmbH | 4 |
| 4 | Azurity Pharmaceuticals Inc | 2 |
| 5 | Laboratoire Aguettant SAS | 2 |
| 6 | National Technology and Engineering Solutions of Sandia LLC | 2 |
| 7 | Anhui Medical University | 1 |
| 8 | Avintiv Specialty Materials LLC | 1 |
| 9 | Ciba Specialty Chemicals Oy | 1 |
| 10 | GlaxoSmithKline Biologicals SA | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 60 |
| 2 | A61P | Therapeutic activity (drug indications) | 35 |
| 3 | A23L | Foods and beverages (general) | 20 |
| 4 | A23V | Foods, foodstuffs - indexing scheme | 18 |
| 5 | C08L | Polymer compositions (blends) | 14 |
| 6 | A61L | Sterilising / disinfecting materials | 13 |
| 7 | C08B | 12 | |
| 8 | A61Q | Cosmetics, personal care | 8 |
| 9 | C08F | Polymers from C=C unsaturated bonds | 8 |
| 10 | C08H | 7 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Burkhard Madea | University of Bonn | 7 |
| 2 | Frank Mußhoff | University of Bonn | 7 |
| 3 | Uta Kuepper | University of Bonn | 7 |
| 4 | Frank Herbstreit | Essen University Hospital | 2 |
| 5 | Bo Zhang | Jiangsu Provincial Center for Disease Control and Prevention | 1 |
| 6 | Catherine Doro | Liverpool College | 1 |
| 7 | Charles Quenzer | Federal Bureau of Investigation | 1 |
| 8 | E. Silk | 1 | |
| 9 | F. F. Foldes | University of Pittsburgh | 1 |
| 10 | F. F. Földes | Mercy Medical Center | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument | 2006 | 39 | Anesthesia and Sedative Agents |
| Drug storage: a cautionary note. | 1986 | 1 | Pharmaceutical studies and practices |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and chemical structure of Succinylmonocholine?
Which organization holds the most patents for Succinylmonocholine?
What is the publication trend for research on Succinylmonocholine?
Which researchers are most active in publishing about Succinylmonocholine?
What are the primary patent classification areas for Succinylmonocholine?